Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC
NCT01795794
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
CDA Type I
Interventions
DRUG:
omeprazole
Sponsor
Soroka University Medical Center